AMANDA WARNER: Open Payments
NPI 1033676275 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 16 payments from 9 companies in 2025. Trend: 2023 $55 · 2024 $265 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $89 |
| Xeris Pharmaceuticals, Inc. | 3 | $45 |
| Tandem Diabetes Care, Inc. | 2 | $29 |
| Medtronic, Inc. | 2 | $29 |
| BETA BIONICS, INC. | 1 | $24 |
| CeQur Corporation | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Sequel Med Tech, LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: FREESTYLE LIBRE 3, GVOKE HYPOPEN, t:slim X2 Insulin Pump with Control-IQ, INPEN SMART INSULIN DELIVERY SYSTEM, iLet Bionic Pancreas, CeQur Simplicity, AREXVY, TWIIST.
Industry payments across IN — which companies pay providers there.
